Related Experiment Video

Updated: Sep 28, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth

Ming-Tat Ling1, Xianghong Wang, Xue-Song Ouyang

  • 1Cancer Biology Laboratory, Department of Anatomy, Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.

Oncogene
|December 6, 2002
PubMed

Insights

The helix-loop-helix protein Id-1 promotes prostate cancer cell growth by activating the MAPK signaling pathway. Inhibiting this pathway reduces cancer cell proliferation, revealing a novel mechanism for Id-1 in tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The helix-loop-helix Id-1 protein is implicated in the proliferation and tumorigenesis of various human cancers.
  • The precise molecular mechanisms underlying Id-1's function, particularly in prostate cancer, remain largely unelucidated.

Purpose of the Study:

  • To investigate the role of the MAPK signaling pathway in Id-1-mediated serum-independent prostate cancer cell growth.
  • To elucidate the molecular mechanism by which Id-1 influences prostate cancer progression.

Main Methods:

  • Utilized stable Id-1 transfectant clones of prostate cancer cells (LNCaP).
  • Examined the activation of the Raf/MEK1/2 signaling pathway in response to Id-1 expression.
  • Assessed the impact of MEK1/2 inhibition (PD098059) on cell cycle progression and growth.
  • Investigated Id-1 and Egr-1 expression levels using antisense oligonucleotides in PC-3 and DU145 cells.

Main Results:

  • Ectopic Id-1 expression activated the Raf/MEK1/2 signaling pathway in LNCaP cells.
  • Inhibition of MEK1/2 phosphorylation decreased prostate cancer cell growth and S phase fraction, confirming MAPK pathway's essential role.
  • Antisense oligonucleotide treatment reduced Id-1 expression and subsequently decreased Egr-1 protein levels in PC-3 and DU145 cells.

Conclusions:

  • Id-1 function is linked to the activation of the MAPK signaling pathway.
  • This study identifies a novel mechanism involving Id-1 and MAPK signaling in regulating prostate cancer cell growth and tumorigenesis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...